Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 2208.HK
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 6.19 1.08 1.01
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 73.52 33.55 19.34
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -27.07 8.27 11.34
Cash -44.99 2.48 4.51
Capex 73.69 -0.16 -0.60
Free Cash Flow 6.57 -1.48 1.39
Revenue -76.10 1.52 6.37
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 57.99 0.26 0.17
Operating Margin 273.17 0.08 0.02
ROA 378.47 < 0.005 < 0.005
ROE 370.05 < 0.005 < 0.005
ROIC 117.63 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 2208.HK is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 2208.HK is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 2208.HK is permitted for members.